Event Type
Disclosure
Voluntary
Variant
8-K
Other Events On January 28, 2026, BioNexus Gene Lab Corp. (the “Company”) issued a press release announcing the formal commencement of its 2026 regional deploym
Financial Statement and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 28, 2026 104 Cover Page Interactive Data File (embedde